Y-Intercept (HK)’s iShares Biotechnology ETF IBB Stock Holding History

Y-Intercept (HK)’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.76M	Buy	+30,280	New	+$5.2M	0.11%	239
2025 Q1	–	Sell	-3,863	Closed	-$511K	–	1384
2024 Q4	$511K	Buy	+3,863	New	+$543K	0.03%	713
2024 Q2	–	Sell	-1,824	Closed	-$250K	–	1613
2024 Q1	$250K	Buy	+1,824	New	+$249K	0.02%	1053
2021 Q4	–	Sell	-6,857	Closed	-$1.11M	–	705
2021 Q3	$1.11M	Buy	6,857 +3,918	+133%	+$659K	0.2%	162
2021 Q2	$481K	Sell	2,939 -1,532	-34%	-$236K	0.12%	273
2021 Q1	$656K	Buy	+4,471	New	+$710K	0.18%	186

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Y-Intercept (HK)'s IBB Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in iShares Biotechnology ETF (IBB) in Q2 2026: 30,280 shares worth $5.76M. The stake represents 0.11% of the portfolio and ranks #239 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in IBB as recently as Q4 2024.

Y-Intercept (HK) first reported a position in IBB in Q1 2021 and has held it in 6 quarters since. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Y-Intercept (HK) held 30,280 shares of iShares Biotechnology ETF worth $5.76M as of Q2 2026.
iShares Biotechnology ETF was a new Y-Intercept (HK) position in Q2 2026.
iShares Biotechnology ETF made up 0.11% of Y-Intercept (HK)'s portfolio in Q2 2026, its #239 holding.
Y-Intercept (HK) first reported a position in iShares Biotechnology ETF in Q1 2021 and has held it in 6 quarters since.
956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.